Dandelion Biosciences was founded by Chris, in Singapore at late 2022. We are dedicated to advancing drug discovery research services globally. With a robust team of experienced scientists, we specialize in providing comprehensive solutions for pharmaceutical, biotechnology companies, as well as academic institutes seeking to develop best-in-class therapeutics. Our services encompass a wide range of areas including target identification, hit identification, lead optimization, and preclinical development. Utilizing our proprietary UCeP technologies and know-hows, we strive to accelerate your drug discovery process and bring your transformative medicines to market efficiently. Committed to excellence, integrity, and scientific rigor, our company is your trusted partner in driving innovation and improving research efficiency in your drug discovery and biology research.